Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AL amyloidosis
AL amyloidosis
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
EP Vantage
Wed, 09/29/21 - 10:58 am
AL amyloidosis
Darzalex
AstraZeneca
clinical trials
CAEL-101
Caelum Biosciences
Prothena revives its former lead drug, aiming for a smaller population with more severe cases
Endpoints
Wed, 02/3/21 - 10:59 pm
Prothena
NEOD001
clinical trials
AL amyloidosis
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
Endpoints
Mon, 06/15/20 - 10:51 am
EHA
JNJ
clinical trials
Darzalex
AL amyloidosis
ASH: Takeda details Ninlaro's miss in scrapped AL amyloidosis trial
Fierce Pharma
Mon, 12/9/19 - 09:59 am
ASH2019
Takeda
Nilaro
AL amyloidosis
After AL amyloidosis flop, Prothena slashes workforce by 57%
Fierce Biotech
Fri, 05/25/18 - 10:08 am
Prothena
R&D
Celgene
AL amyloidosis
layoffs
Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage
Endpoints
Mon, 04/23/18 - 09:14 am
Prothena
AL amyloidosis
clinical trials
NEOD001